About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read more
- Annual Report 2017PDF - 9.0MB
- Responsible Business Supplement 2017PDF - 3.6MB
We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.
Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers and make GSK a brilliant place to work.
Our values are Patient focus, Transparency, Respect, Integrity.
Our expectations are Courage, Accountability, Development, Teamwork.
What we do
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
Pharmaceuticals
Our Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, use of genetics and advanced technologies.
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. We deliver over two million vaccine doses per day to people living in over 160 countries.
Consumer Healthcare
Our Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert recommended brands in the Pain relief, Respiratory, Digestive health, Oral health, Nutrition and Skin health categories.
How we do it
Everyone at GSK is focused on 3 priorities – Innovation, Performance, Trust
Innovation
We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.
-
£3.9bn
R&D investment in 2017
-
3
major launches in 2017 – Shingrix, a vaccine for shingles, Trelegy Ellipta for COPD and Juluca for HIV
-
£6.7bn
new product sales in Pharmaceuticals and Vaccines in 2017
-
13%
Consumer Healthcare sales in 2017 from product innovations launched over the past three years
Performance
We aim to achieve industry-leading growth by investing effectively in our business, developing our people and delivering flawlessly.
-
£30.2bn
total turnover in 2017
-
£8.6bn
adjusted operating profit in 2017
-
£3.4bn
free cash flow in 2017
-
£3.9bn
dividends paid in 2017
Trust
We are a responsible company and commit to use our science and technology to address health needs, make our products affordable and available and to be a modern employer.
-
85%
of employees proud to work at GSK
-
£261.6m
donated in 2017 to local communities through product donations, time and cash
-
1st
in Access to Medicines Index all 5 times since its launch in 2008
Find out more about us
-
Our history
-
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
-
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
-
Governance
At GSK we are committed to operating at the highest standards of corporate governance. We believe our governance structure underpins our ability to deliver the Group's strategy to create long-term value and benefit for our shareholders and stakeholders.
-
Policies, codes and standards
Find out more about the GSK Code of Conduct and our Anti-Bribery and Corruption programme
